M. Goffinet

P2Y13 Receptor Regulates HDL Metabolism and Atherosclerosis In Vivo

N. Lalwani, C. Tardy, N. Boubekeur, 2014, PloS one.

HDL and CER-001 Inverse-Dose Dependent Inhibition of Atherosclerotic Plaque Formation in apoE-/- Mice: Evidence of ABCA1 Down-Regulation

J. Paolini, N. Lalwani, C. Tardy, 2015, PloS one.

CER-001, a HDL-mimetic, stimulates the reverse lipid transport and atherosclerosis regression in high cholesterol diet-fed LDL-receptor deficient mice.

J. Paolini, N. Lalwani, C. Tardy, 2014, Atherosclerosis.

Factors affecting pharmacokinetic variability of oral topotecan: a population analysis

J. Verweij, A. Sparreboom, W. Loos, 2004, British Journal of Cancer.

Zoledronic acid treatment impairs protein geranyl-geranylation for biological effects in prostatic cells

M. Thoulouzan, C. Weinbaum, I. Lajoie-Mazenc, 2006, BMC Cancer.

Identification of a GTP-bound Rho specific scFv molecular sensor by phage display selection

G. Favre, J. Faye, P. Chinestra, 2008, BMC biotechnology.

Mechanism‐based models for topotecan‐induced neutropenia

J. Verweij, A. Sparreboom, R. Mathijssen, 2004, Clinical pharmacology and therapeutics.